Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07103356 · ClinicalTrials.gov registry record · NA

Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire

A NA study of Environmental Exposure and Arsenic Poisoning, sponsored by Trustees of Dartmouth College.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07103356: Recruiting NA study of Environmental Exposure and Arsenic Poisoning, sponsored by Trustees of Dartmouth College.

NCT07103356 is a NA study of Environmental Exposure and Arsenic Poisoning that is actively recruiting participants, run by Trustees of Dartmouth College. The registered enrollment target is 20 participants, below the 289-participant average among 13 other Environmental Exposure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07103356, a NA study of Environmental Exposure and Arsenic Poisoning, is actively recruiting participants, sponsored by Trustees of Dartmouth College.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goals of this clinical trial are to: 1. gather preliminary data on the effectiveness of a table-top water pitcher filtration system in reducing arsenic exposure among individuals using private wells with elevated (\>5 μg/L) arsenic concentrations, and 2. identify the factors influencing implementation of the filter intervention (uptake and sustainability) and barriers and facilitators to its use. The main questions it aims to answer are: Do water and urinary arsenic concentrations change from baseline to Week 4 of the water pitcher intervention? Are changes in arsenic concentrations maintained during the eight-week sustainability period? * Which factors facilitate or impede uptake, use, and sustainability of the intervention? * Are household income and/or home ownership associated with sustained filter use? Participants will: * Receive a free 12-cup water filter pitcher and cartridge replacements * Use the pitcher filtration system, including replacement of filter cartridges, per manufacturer recommendations * Collect and mail water and urine samples at baseline, 4 weeks, and 12 weeks * Complete online questionnaires at baseline, 4 weeks, and 12 weeks

Primary Outcome

Changes in water arsenic concentrations from baseline to week 4

Interventions

  • BEHAVIORAL Water Pitcher Filtration System

Study Locations (1)

New Hampshire

  • Geisel School of Medicine at Dartmouth - Lebanon

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-02-15
Est. Completion 2027-08-31
Phase NA
Trustees of Dartmouth College

31 total trials

What NCT07103356 shows while recruiting

NCT07103356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 289-participant average among 13 other Environmental Exposure trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Environmental Exposure appearing as the primary indexed condition, and to 1 intervention - of which Water Pitcher Filtration System is the first listed.

NCT07103356 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT07103356 about?

NCT07103356 is a clinical study titled "Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire". The goals of this clinical trial are to: 1. gather preliminary data on the effectiveness of a table-top water pitcher filtration system in reducing arsenic exposure among individuals using private wells with elevated (\>5 μg/L) arsenic concentrations, and 2. identify the factors influencing impleme...

What is the current status of trial NCT07103356?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-02-15. Estimated completion is 2027-08-31.

What conditions does trial NCT07103356 study?

This clinical trial studies the following conditions: Environmental Exposure, Arsenic Poisoning, Water-Related Diseases.

What interventions are being tested in trial NCT07103356?

The interventions under investigation include: Water Pitcher Filtration System (BEHAVIORAL).

Who is sponsoring clinical trial NCT07103356?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07103356 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Environmental Exposure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07103356's enrollment target sits among peer trials

20 9th of 13 higher than 3 of 13 other Environmental Exposure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Environmental Exposure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07103356, the US trial registry maintained by the National Library of Medicine. NCT07103356 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.